Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Cancer Clin Oncol. 2012 Dec 21;2(1):51–61. doi: 10.5539/cco.v2n1p51

Figure 6. Survival with respect to combined p16 and HPV16 status.

Figure 6

For all sites combined, when compared to the p16 positive/HPV16 positive cases, patients with p16 positive/HPV16 negative and p16 negative/HPV16 positive had poorer survival. p16 negative/HPV16 negative status had the worst survival. (p16+ve – p16 positive, p16-ve – p16 negative, HPV+ve – HPV16 positive, HPV-ve – HPV16 negative)